HOME SEARCH RSS FEED SUBSCRIBE

Search Results - lillie+leach

2 Results Sort By:
Novel Costimulatory Platform for CAR-Based Adoptive Cell Therapies
Ineffective targeting of current CAR T Chimeric antigen receptor (CAR) T cell therapy is a powerful treatment tool for multiple types of malignancies. There are six FDA approved CAR T therapies that have demonstrated efficacy in patients who are refractory to standard chemotherapy, with many patients entering remission after treatment. However, most...
Published: 10/23/2023   |   Inventor(s): Mark Kohler, Terry Fry, Catherine Danis, Lillie Leach
Disease Areas Regenerative Medicine
Category(s): Therapeutics
Novel Costimulatory Platform for CAR-Based Adoptive Cell Therapies
Ineffective targeting of current CAR T Chimeric antigen receptor (CAR) T cell therapy is a powerful treatment tool for multiple types of malignancies. There are six FDA approved CAR T therapies that have demonstrated efficacy in patients who are refractory to standard chemotherapy, with many patients entering remission after treatment. However, most...
Published: 10/23/2023   |   Inventor(s): Mark Kohler, Catherine Danis, Terry Fry, Lillie Leach
Disease Areas Regenerative Medicine
Category(s): Therapeutics
Home | Search | RSS | Subscribe
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum